Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial

S. Vincent Rajkumar, Susanna Jacobus, Natalie S. Callander, Rafael Fonseca, David H. Vesole, Michael E. Williams, Rafat Abonour, David S. Siegel, Michael Katz, Philip R. Greipp

Research output: Contribution to journal › Article › peer-review

734 Scopus citations

Fingerprint

Dive into the research topics of 'Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences